Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Malignant Melanoma

Free Subscription 05.04.2021 1 Am J Surg 1 Ann Surg Oncol 1 Anticancer Res 1 Biochem Biophys Res Commun 1 Br J Dermatol 1 Cancer 1 J Immunol 2 J Invest Dermatol 1 J Surg Oncol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Surg

1. ARNOT SP, Han G, Fortino J, Han D, et al
   Utility of a 31-gene expression profile for predicting outcomes in patients with primary cutaneous melanoma referred for sentinel node biopsy.
   Am J Surg. 2021 Mar 17. pii: S0002-9610(21)00163.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

2. AHMADI O, Das M, Hajarizadeh B, Mathy JA, et al
   Impact of Shave Biopsy on Diagnosis and Management of Cutaneous Melanoma: A Systematic Review and Meta-Analysis.
   Ann Surg Oncol. 2021 Mar 29. pii: 10.1245/s10434-021-09866.
   PubMed         Abstract available
   
   

   
   Anticancer Res

3. LEE Y, Park D
   Effect of Metformin in Combination With Trametinib and Paclitaxel on Cell Survival and Metastasis in Melanoma Cells.
   Anticancer Res. 2021;41:1387-1399.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

4. LOPES JC, Botelho FV, Barbosa Silva MJ, Silva SF, et al
   In vitro and in vivo antitumoral activity of a ternary copper (II) complex.
   Biochem Biophys Res Commun. 2020;533:1021-1026.
   PubMed         Abstract available
   
   

   
   Br J Dermatol

5. MARLEY AR, Li M, Champion VL, Song Y, et al
   The Association between Citrus Consumption and Melanoma Risk in the UK Biobank.
   Br J Dermatol. 2021 Mar 30. doi: 10.1111/bjd.19896.
   PubMed         Abstract available
   
   

   
   Cancer

6. KEMPF E, Zalcman G, Lebbe C
   National early access programs and clinical trials: What opportunities for early access to therapeutic innovations for patients with malignant melanoma?
   Cancer. 2021 Mar 31. doi: 10.1002/cncr.33495.
   PubMed        
   
   

   
   J Immunol

7. OBA T, Hoki T, Yamauchi T, Keler T, et al
   A Critical Role of CD40 and CD70 Signaling in Conventional Type 1 Dendritic Cells in Expansion and Antitumor Efficacy of Adoptively Transferred Tumor-Specific T Cells.
   J Immunol. 2020;205:1867-1877.
   PubMed         Abstract available
   
   

   
   J Invest Dermatol

8. AL EMRAN A, Tseng HY, Gunatilake D, Cook SJ, et al
   A combination of epigenetic BET and CDK9 inhibitors for treatment of human melanoma.
   J Invest Dermatol. 2021 Mar 26. pii: S0022-202X(21)01121.
   PubMed         Abstract available
   
   
9. HUANG SW, Wang ST, Chang SH, Chuang KC, et al
   Imiquimod Exerts Antitumor Effects by Inducing Immunogenic Cell Death and Is Enhanced by the Glycolytic Inhibitor 2-Deoxyglucose.
   J Invest Dermatol. 2020;140:1771-1783.
   PubMed         Abstract available
   
   

   
   J Surg Oncol

10. LYNCH KT, Kane WJ, Fleming MA, Desai RP, et al
    Childhood cancer survivors face markedly worse overall survival after diagnosis with breast cancer, melanoma, or colorectal cancer.
    J Surg Oncol. 2021 Mar 31. doi: 10.1002/jso.26478.
    PubMed         Abstract available
    
    

    
    PLoS One

11. LEE YS, Heo W, Choi HJ, Cho HR, et al
    An inhibitor of programmed death ligand 1 enhances natural killer cell-mediated immunity against malignant melanoma cells.
    PLoS One. 2021;16:e0248870.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: